R. Scott Greer Joins Inogen Board of Directors

Go back to R. Scott Greer Joins Inogen Board of Directors

StemCells (STEM) Reports In-Line Q2 EPS

August 6, 2015 4:36 PM EDT

StemCells (NASDAQ: STEM) reported Q2 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $30 thousand versus the consensus estimate of $30 thousand.

"Our clinical programs achieved several key milestones since our last earnings release," reported StemCells... More